価格表

在庫・価格 : 2024年03月28日 22時54分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CRISPR/Cas9, Mouse-Mono(7A9)
データシート
A-9000-010 EPGエピジェンテックグループ
Epigentek Group Inc.
10 μg ¥17,000
(未発注)
追加

在庫・価格 : 2024年03月28日 22時54分 現在

Anti-CRISPR/Cas9, Mouse-Mono(7A9)

  • 商品コード:A-9000-010
  • メーカー:EPG
  • 包装:10μg
  • 価格: ¥17,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fuller KK et al. Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell 2015 Nov;14(11):1073-80
Fuller KK et al
2015/01/01
PubMed
2 Wang D et al. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Hum. Gene Ther. 2015 Jul;26(7):432-42
Wang D et al
2015/01/01
PubMed
3 Chew WL et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 2016 Oct;13(10):868-74
Chew WL et al
2016/01/01
PubMed
4 Li S et al. One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes. Mol Ther Nucleic Acids 2017 Sep;8:64-76
Li S et al
2017/01/01
PubMed
5 Behler J et al. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system. Nat Microbiol 2018 03;3(3):367-377
Behler J et al
2018/01/01
PubMed
6 Hu J et al. A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Mol Ther Methods Clin Dev 2018 Jun;9:203-210
Hu J et al
2018/01/01
PubMed
7 Ophinni Y et al. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures. Sci Rep 2018 May;8(1):7784
Ophinni Y et al
2018/01/01
PubMed
8 Chen H et al. Efficient Genome Editing of <i>Magnetospirillum magneticum</i> AMB-1 by CRISPR-Cas9 System for Analyzing Magnetotactic Behavior. Front Microbiol 2018;9:1569
Chen H et al
2018/01/01
PubMed
9 Yarrington RM et al. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proc. Natl. Acad. Sci. U.S.A. 2018 09;115(38):9351-9358
Yarrington RM et al
2018/01/01
PubMed
10 Rossidis AC et al. In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat. Med. 2018 10;24(10):1513-1518
Rossidis AC et al
2018/01/01
PubMed
11 McInally SG et al. Robust and stable transcriptional repression in Giardia using CRISPRi. Mol Biol Cell 2019 01;30(1):119-130
McInally SG et al
2019/01/01
PubMed
12 Ajina R et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology ;8(5):e1577127
Ajina R et al
PubMed
13 Moran JD et al. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int. J. Oncol. 2019 Aug;55(2):359-370
Moran JD et al
2019/01/01
PubMed
14 Taghbalout A et al. Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways. Nat Commun 2019 09;10(1):4296
Taghbalout A et al
2019/01/01
PubMed
15 Jiang T et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat Commun 2020 04;11(1):1979
Jiang T et al
2020/01/01
PubMed
16 Yang D et al. The microRNA/TET3/REST axis is required for olfactory globose basal cell proliferation and male behavior. EMBO Rep 2020 09;21(9):e49431
Yang D et al
2020/01/01
PubMed
17 Glykofridis IE et al. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells. Elife 2021 Jan;10
Glykofridis IE et al
2021/01/01
PubMed
18 Aparicio Prat E. et. al.Roadmap for the use of Base Editors to Decipher Drug Mechanism of Action., Research Square.,

PubMed
19 Lewis M., et al., A genomeテ「竄ャツ尽cale CRISPR knockテ「竄ャツ塵ut screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling., Cancer Medicine.,

PubMed
20 Somerville T.D.D et al.Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation., bioRxiv.,

PubMed
  • No.: 1
  • 文献情報:
    Fuller KK et al. Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell 2015 Nov;14(11):1073-80
    Fuller KK et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wang D et al. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Hum. Gene Ther. 2015 Jul;26(7):432-42
    Wang D et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Chew WL et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 2016 Oct;13(10):868-74
    Chew WL et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Li S et al. One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes. Mol Ther Nucleic Acids 2017 Sep;8:64-76
    Li S et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Behler J et al. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system. Nat Microbiol 2018 03;3(3):367-377
    Behler J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Hu J et al. A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Mol Ther Methods Clin Dev 2018 Jun;9:203-210
    Hu J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ophinni Y et al. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures. Sci Rep 2018 May;8(1):7784
    Ophinni Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chen H et al. Efficient Genome Editing of <i>Magnetospirillum magneticum</i> AMB-1 by CRISPR-Cas9 System for Analyzing Magnetotactic Behavior. Front Microbiol 2018;9:1569
    Chen H et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yarrington RM et al. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proc. Natl. Acad. Sci. U.S.A. 2018 09;115(38):9351-9358
    Yarrington RM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Rossidis AC et al. In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat. Med. 2018 10;24(10):1513-1518
    Rossidis AC et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    McInally SG et al. Robust and stable transcriptional repression in Giardia using CRISPRi. Mol Biol Cell 2019 01;30(1):119-130
    McInally SG et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ajina R et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology ;8(5):e1577127
    Ajina R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Moran JD et al. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int. J. Oncol. 2019 Aug;55(2):359-370
    Moran JD et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Taghbalout A et al. Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways. Nat Commun 2019 09;10(1):4296
    Taghbalout A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Jiang T et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat Commun 2020 04;11(1):1979
    Jiang T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Yang D et al. The microRNA/TET3/REST axis is required for olfactory globose basal cell proliferation and male behavior. EMBO Rep 2020 09;21(9):e49431
    Yang D et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Glykofridis IE et al. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells. Elife 2021 Jan;10
    Glykofridis IE et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Aparicio Prat E. et. al.Roadmap for the use of Base Editors to Decipher Drug Mechanism of Action., Research Square.,

  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lewis M., et al., A genomeテ「竄ャツ尽cale CRISPR knockテ「竄ャツ塵ut screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling., Cancer Medicine.,

  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Somerville T.D.D et al.Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation., bioRxiv.,

  • 備考:
  • 参照:
    PubMed